Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This new systematic review and meta-analysis of randomised controlled trials assesses the effects of statins given alone, without concomitant antidepressant treatment, in people with depressive symptoms, but who do not have a formal diagnosis of a depressive disorder.

Half of statins tablets pill in female patient hand and white blister pack of them for light resistance packaging on white background

Statins are among the most prescribed medications worldwide, useful for preventing and treating heart and metabolic diseases. However, they also have anti-inflammatory effects, which make them interesting candidates for the treatment of depression, as this mental disorder has been linked to excessive inflammation. 

In this new study, The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis, researchers pooled data from fourteen randomised controlled trials, which compared a statin given alone against placebo (a "dummy tablet"). A total of 2,712 people who were affected by depressive symptoms were involved in these trials. In this analysis, however, statins did not seem to make any difference in terms of improving or indeed worsening depressive symptoms.

A previous study, Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials, had shown promising evidence that statins, given along with antidepressants, may help in reducing depressive symptoms in patients who had been formally diagnosed with depression. However, it was still unclear whether statins could improve depressive symptoms regardless of a concurrent use of antidepressant medications.

Taken together, these findings suggest that statins do not decrease milder depressive symptoms on their own. However, statins plus antidepressants, compared to an antidepressant alone, appear to improve depression in patients who are most affected by it. 

Dr Riccardo De Giorgi, study author and Wellcome Trust Doctoral Training Fellow, University of Oxford, said:


'Our "null findings" are important because they suggest that statins, some very commonly prescribed drugs, do not change mood in the general population – in other words, they can be considered quite safe. According to our previous study, statins might improve depression in people diagnosed with this disorder, but only when given in addition to an antidepressant. Larger studies are needed to confirm the latest evidence, but overall, our results are significant because they suggest that future clinical trials should focus on this add-on use of statins and antidepressants, compared to statins alone, for the treatment of depression.'

Read the full study, The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis, published in Journal of Affective Disorders.


Please follow the link below to read the news on the NIHR BRC website.

Similar stories

‘Thinking Family’ when an adult has a serious illness

New research shows that although patient’s family details were often recorded, this information was not routinely used to help patients share their diagnosis with children.

Treating mental illness with electricity - new podcast

A new wave of treatments that stimulate the brain with electricity are showing promise on patients and in clinical trials.

Hours of gaming not negatively impacting wellbeing of most adolescents - new study

University of Oxford researchers found that although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.

Few mental health apps make it to real world, according to new Oxford University study

Despite enthusiasm for digital technology in addressing young people’s mental health, few effective apps have been successfully rolled out.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Dementia research - new trial with diabetes drug

An important new trial will test the effects of oral semaglutide on the build-up of a protein in the brain that characterises Alzheimer's disease.